Evidence map›Paper›PMID 34835992›Full record

ArticleNutrients2021

A Novel UC Exclusion Diet and Antibiotics for Treatment of Mild to Moderate Pediatric Ulcerative Colitis: A Prospective Open-Label Pilot Study.

Chen Sarbagili-Shabat, Lindsey Albenberg, Johan Van Limbergen, Naomi Pressman, Anthony Otley, Michal Yaakov, Eytan Wine, Dror Weiner, Arie Levine

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05791487 (Remission With Diet for Ulcerative Colitis Exacerbations), which is not on this map. Cited by 33 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 3 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05791487 narecruitingnot on this mapstarted 2023, after this paper: background citation

Remission With Diet for Ulcerative Colitis Exacerbations: A Single Blinded, International Randomized Controlled Clinical and Translational Trial

TypeinterventionalSponsorWolfson Medical CenterRan2023 to 2026Enrolled90ConditionsUlcerative Colitis, Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic ModerateArmsUlcerative colitis Exclusion Diet, Partial enteral nutrition (PEN), free diet, Oral Budesonide
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 3 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Plant and Animal Protein Sources in Inflammatory Bowel Disease: Current Evidence and Clinical Implications.JGH open : an open access journal of gastroenterology and hepatology · 2026
    Review
  5. Review
  6. Review
  7. Single-center experience of the Crohn's disease exclusion diet in the United States: A retrospective study.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2026
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

Chen Sarbagili-ShabatPIBD Research Center, Paediatric Gastroenterology and Nutrition Unit, The E. Wolfson Medical Center, Holon 5822012, Israel.
Lindsey AlbenbergDivision of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Johan Van LimbergenDivision of Pediatric Gastroenterology and Nutrition, Department of Pediatrics, Amsterdam University Medical Centers, Emma Children's Hospital, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0001-5822-4371
Naomi PressmanDivision of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Anthony OtleyDivision of Gastroenterology and Nutrition, IWK Health Center, Halifax, NS B3K 6R8, Canada.
Michal YaakovPIBD Research Center, Paediatric Gastroenterology and Nutrition Unit, The E. Wolfson Medical Center, Holon 5822012, Israel.
Eytan WineDepartments of Pediatrics and Physiology, University of Alberta, Edmonton, AB T6G 2R3, Canada.ORCID 0000-0002-3458-4142
Dror WeinerPIBD Research Center, Paediatric Gastroenterology and Nutrition Unit, The E. Wolfson Medical Center, Holon 5822012, Israel.
Arie LevinePIBD Research Center, Paediatric Gastroenterology and Nutrition Unit, The E. Wolfson Medical Center, Holon 5822012, Israel.
Children's Hospital of Philadelphia · USTel Aviv University · ILWolfson Medical Center · ILAmsterdam UMC Location University of Amsterdam · NLIzaak Walton Killam Health Centre · CAUniversity of Alberta · CA

Funding

Azrieli Israel donationThe Solomon Foundation donation
6 · The paper itself

Abstract

backgroundAs the microbiome plays an important role in instigating inflammation in ulcerative colitis (UC), strategies targeting the microbiome may offer an alternative therapeutic approach. The goal of the pilot trial was to evaluate the potential efficacy and feasibility of a novel UC exclusion diet (UCED) for clinical remission, as well as the potential of sequential antibiotics for diet-refractory patients to achieve remission without steroids.

methodsThis was a prospective, single-arm, multicenter, open-label pilot study in patients aged 8-19, with pediatric UC activity index (PUCAI) scores >10 on stable maintenance therapy. Patients failing to enter remission (PUCAI < 10) on the diet could receive a 14-day course of amoxycillin, metronidazole and doxycycline (AMD), and were re-assessed on day 21. The primary endpoint was intention-to-treat (ITT) remission at week 6, with UCED as the only intervention.

resultsTwenty-four UCED treatment courses were given to 23 eligible children (mean age: 15.3 ± 2.9 years). The median PUCAI decreased from 35 (30-40) at baseline to 12.5 (5-30) at week 6 (

conclusionThe UCED appears to be effective and feasible for the induction of remission in children with mild to moderate UC. The sequential use of UCED followed by antibiotic therapy needs to be evaluated as a microbiome-targeted, steroid-sparing strategy.

Indexed as

AdolescentAmoxicillinAnti-Bacterial AgentsChildColitis, UlcerativeDoxycyclineDrug Therapy, CombinationEatingFemaleHumansIntention to Treat AnalysisMaleMetronidazoleNutritional StatusPatient CompliancePilot ProjectsAmoxicillinAnti-Bacterial AgentsDoxycyclineMetronidazoleantibioticschilddietremissiontreatmentulcerative colitis

Identifiers

PMID34835992
PMCPMC8622458
OpenAlexW3209322648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.